Qube Research & Technologies (QRT)
BBOT

Qube Research & Technologies (QRT)’s BridgeBio Oncology BBOT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$644K Buy
71,925
+35,973
+100% +$386K ﹤0.01% 2656
2025
Q4 		$450K Buy
+35,952
New +$436K ﹤0.01% 2830

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BBOT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its BridgeBio Oncology (BBOT) stake by 100% in Q1 2026, buying an estimated $386K and bringing the position to 71,925 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Qube Research & Technologies (QRT) first reported a position in BBOT in Q4 2025 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • Qube Research & Technologies (QRT) held 71,925 shares of BridgeBio Oncology worth $644K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 35,973 BridgeBio Oncology shares in Q1 2026, an estimated $386K.
  • BridgeBio Oncology made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2656 holding.
  • Qube Research & Technologies (QRT) first reported a position in BridgeBio Oncology in Q4 2025 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.